Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
06/2000
06/20/2000US6077529 Applying lipid transfer protein in aqueous solution to surface of lung and oronasal passage
06/20/2000US6077528 Percutaneous preparation
06/20/2000US6077527 Alkyl (meth)acrylate-substituted (meth)acrylamide copolymer; titanium or aluminum chelated metal oxide crosslinker; cutaneous penetration enhancer
06/20/2000US6077524 Gastric acid binding chewing pastilles
06/20/2000US6077523 Process to manufacture implants containing bioactive peptides
06/20/2000US6077513 Drug for treatment of bilharziasis (Schistosomiasis)
06/20/2000US6077502 Oral care compositions comprising chlorite and methods
06/20/2000CA2164619C Once-a-day metoprolol oral dosage form
06/20/2000CA2144845C Germicidal detergent-iodine compositions having reduced detergent content
06/20/2000CA2125284C Peroral administration form for peptidic medicaments, in particular insulin
06/20/2000CA2026505C Therapeutical elements for the oral administration of a medicament to animals and process for their preparation
06/20/2000CA2011262C Use of mixed micelles
06/20/2000CA2001618C Gestodene-containing agent for transdermal administration
06/15/2000WO2000034451A1 Treatment of pompe's disease
06/15/2000WO2000034308A2 Protein transduction system and methods of use thereof
06/15/2000WO2000034293A1 Method for preparation of disodium pamidronate
06/15/2000WO2000033979A1 Apparatus for separating particles of cohesive material according to size and process
06/15/2000WO2000033917A1 Agents provided for treating tumors, based on liposomes, and containing tamoxifen
06/15/2000WO2000033893A1 Sterile complex of therapeutic peptide bond to a polysaccharide
06/15/2000WO2000033892A1 A medicinal aerosol formulation
06/15/2000WO2000033877A1 Anhydrous topical skin preparations
06/15/2000WO2000033869A2 Use of human prostrate cell lines in cancer treatment
06/15/2000WO2000033866A1 Pharmaceutical compositions containing insulin
06/15/2000WO2000033863A2 Therapeutic agent for the suppression of snoring noises
06/15/2000WO2000033862A1 Self-emulsifying compositions for drugs poorly soluble in water
06/15/2000WO2000033861A2 Pharmaceutical compositions containing protein-disulfide isomerases
06/15/2000WO2000033847A1 Micronized eplerenone compositions
06/15/2000WO2000033835A1 Controlled-release dosage forms comprising zolpidem or a salt thereof
06/15/2000WO2000033833A1 Palladium-substituted bacteriochlorophyll derivatives and use thereof
06/15/2000WO2000033832A1 Chemical composition for treating cervical intraepithelial neoplasia i, ii, iii, iv and cervicitis
06/15/2000WO2000033825A2 Compositions and methods for amelioration of human female sexual dysfunction
06/15/2000WO2000033823A2 Methods of using temozolomide in the treatment of cancers
06/15/2000WO2000033822A1 Active ingredient matrix in the form of a biologically resorbable porous non-woven made of collagen fibrils, method for the production and use thereof
06/15/2000WO2000033821A1 Enteric coated pravastatin bead formulation
06/15/2000WO2000033820A2 Nanoparticulate core-shell systems and use thereof in pharmaceutical and cosmetic preparations
06/15/2000WO2000033819A1 Method for producing agglomerates comprising a core-shell structure
06/15/2000WO2000033818A1 Sustained release tablet containing hydrocolloid and cellulose ether
06/15/2000WO2000033817A1 Phospholipid compositions
06/15/2000WO2000033816A1 Formulation for delivery of particulate material to mucosal membranes
06/15/2000WO2000033815A1 Fungicide-containing powdery aerosol preparations
06/15/2000WO2000033814A2 Method for administering agents to the central nervous system
06/15/2000WO2000033813A1 Administration of neurotrophic agents to the central nervous system
06/15/2000WO2000033812A2 Transdermal patch for delivering volatile liquid drugs
06/15/2000WO2000033811A2 Improvements in or relating to powders
06/15/2000WO2000033810A1 Use of vitamin b12 in a nasal composition for delivering active agents to the central nervous system
06/15/2000WO2000033809A1 Compositions containing a peptide and polylactic-glycolic acid suitable for preparing subcutaneous implants with an extended release period
06/15/2000WO2000033805A1 Cosmetic skin care compositions containing 4-chromanone
06/15/2000WO2000033789A2 Inhalation powders
06/15/2000WO2000033786A1 Cleavable solid dosage forms and method for the production thereof
06/15/2000WO2000033775A1 Controlled release system for delivering therapeutic agents into the inner ear
06/15/2000WO2000033764A1 Biocompatible crosslinked polymers
06/15/2000WO2000033673A1 Microparticles and process for making microparticles
06/15/2000WO2000033669A1 Preparation of cholesterol reducing edible products by mixing plant sterols/stanols in a melt of a food emulsifier
06/15/2000WO2000033636A1 Stabilization of ground plant seeds
06/15/2000WO2000013672A9 New solid dose form of nanoparticulate naproxen
06/15/2000WO2000012454A9 Novel polycationic lipids
06/15/2000WO2000011023A3 Ring modified cyclic peptide analogs
06/15/2000WO2000010598A3 Recombinant botulinium toxin for the treatment of mucus hypersecretion
06/15/2000WO2000010536A8 Extended release buccal bioadhesive tablet
06/15/2000WO2000010530A8 Oral liquid mucoadhesive compositions
06/15/2000WO2000009071A3 A novel liposomal formulation useful in treatment of cancer and other proliferation diseases
06/15/2000WO1999061056A9 Methods and products for inducing mucosal immunity
06/15/2000WO1999038503A8 Pharmacological uses of optically pure (+)-bupropion
06/15/2000WO1998051278A3 High efficiency encapsulation of charged therapeutic agents in lipid vesicles
06/15/2000DE19906977C1 Transdermal patch for administering deoxypeganin, useful for treating dementia-associated cognitive impairment and preventing intoxication by organic thiophosphate esters
06/15/2000DE19857425A1 Liquid skin care product, useful e.g. for improving appearance of skin or delivering pharmaceuticals, separates quickly and sharply into oil and aqueous phases after shaking
06/15/2000DE19857349A1 Hautpflege-System Skin care system
06/15/2000DE19857151A1 Powdered, water-soluble chlorhexidine salt, useful e.g. as disinfectant in cosmetics, contains anion from specific sugar acids or their lactones
06/15/2000DE19856897A1 Therapeutikum zur Unterdrückung von Schnarchgeräuschen A therapeutic agent for suppressing snoring noises
06/15/2000DE19856668A1 Wirkstoffmatrix in Form eines biologisch resorbierbaren porösen Vlieses, Verfahren zu ihrer Herstellung und Verwendung Active substance matrix in the form of a biologically resorbable porous nonwoven, methods for their preparation and use
06/15/2000DE19856432A1 Nanopartikuläre Kern-Schale Systeme sowie deren Verwendung in pharmazeutischen und kosmetischen Zubereitungen Nanoparticulate core-shell systems and their use in pharmaceutical and cosmetic preparations
06/15/2000DE19856149C1 Verfahren zur Herstellung von Agglomeraten mit Kern-Schale-Struktur A process for producing agglomerates with a core-shell structure
06/15/2000CA2380391A1 Transdermal patch for delivering volatile liquid drugs
06/15/2000CA2354233A1 Self-emulsifying compositions for drugs poorly soluble in water
06/15/2000CA2354044A1 Protein transduction system and methods of use thereof
06/15/2000CA2353942A1 Method for preparation of disodium pamidronate
06/15/2000CA2353809A1 Nanoparticulate core-shell systems and use thereof in pharmaceutical and cosmetic preparations
06/15/2000CA2353522A1 Treatment of pompe's disease
06/15/2000CA2353469A1 Therapeutic agent for the suppression of snoring noises
06/15/2000CA2353104A1 Cosmetic skin care compositions containing 4-chromanone
06/15/2000CA2352250A1 Apparatus for separating particles of cohesive material according to size and process
06/15/2000CA2352178A1 Phospholipid compositions
06/15/2000CA2326842A1 Micronized eplerenone compositions
06/14/2000EP1008851A1 Skin care system
06/14/2000EP1008602A1 Powdered sorbitol and its process for preparation
06/14/2000EP1008380A2 Process and apparatus for mixing or dispersing liquids
06/14/2000EP1008354A1 Immediately disintegrable medicinal compositions
06/14/2000EP1008353A1 Saccharide-containing compositions
06/14/2000EP1008343A1 Rapidly soluble filmy preparation
06/14/2000EP1008342A2 Pharmaceutically active compounds and liposomes, and methods of use thereof
06/14/2000EP1007699A1 Peptide-enhanced transfections
06/14/2000EP1007634A1 Encapsulation of living tissue cells in a microsphere
06/14/2000EP1007551A2 Vaccine against hpv
06/14/2000EP1007181A1 Process for the selection of particles of a preselected size from a particulate pharmaceutical product
06/14/2000EP1007101A2 Improvements in or relating to diagnostic/therapeutic agents
06/14/2000EP1007100A2 Improvements in or relating to contrast agents
06/14/2000EP1007098A2 Down-regulation of gene expression by colorectal administration of synthetic oligonucleotides
06/14/2000EP1007097A1 Formulation of stabilised cationic transfection agent(s)/nucleic acid particles
06/14/2000EP1007094A1 Pharmaceutical compositions for freeze drying
06/14/2000EP1007088A1 Recombinant porcine adenovirus vector
1 ... 2473 2474 2475 2476 2477 2478 2479 2480 2481 2482 2483 2484 2485 2486 2487 2488 2489 2490 2491 2492 2493 ... 2991